When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation

Abstract Background Anecdotal reports suggest that insulin degludec (IDeg) may offer unique health-related quality of life (HRQoL) benefits. As the nature of these benefits remain unclear, this study utilized qualitative research methods to investigate and elucidate the experience of “feeling better...

Full description

Bibliographic Details
Main Authors: James Weatherall, William H. Polonsky, Sally Lanar, Naomi Knoble, Jonas Håkan-Bloch, Elisabeth Constam, Athena Philis-Tsimikas, Alexia Marrel
Format: Article
Language:English
Published: BMC 2018-05-01
Series:Health and Quality of Life Outcomes
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12955-018-0883-1